NEW YORK, Sept. 27 - Sequitur and Discovery Genomics have partnered to screen antisense compounds and study gene function in zebra fish, according to both companies. 

The multiyear agreement calls for Sequitur to use its antisense compounds and high throughput gene expression analysis. Discovery Genomics will bring to the table its functional genomics experience with the zebra fish model. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Labs in the US and South Korea are hoping to bring the woolly mammoth back from beyond extinction, Newsweek writes.

Geneticist Adam Rutherford speaks with National Geographic about paleogenetics, race, and more.

Researchers link genetic links between education and smoking and longevity.

In PNAS this week: influence of gene environment interactions on polygenic traits, epigenetic features affecting fruit fly foraging, and more.